Eating disorder and obsessive-compulsive disorder: Neurochemical and phenomenological commonalities

Journal of Psychiatry and Neuroscience

Volumn 21, Issue 1, 1996, Pages 36-48

  Jarry, Josée L ^a,b   Vaccarino, Franco J ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

cognitions; eating disorders; obsessive compulsive disorders; serotonin

Indexed keywords

CLOMIPRAMINE; DESIPRAMINE; FLUOXETINE; FLUVOXAMINE; SEROTONIN; SERTRALINE;

COGNITION; COMPULSION; FEEDING DISORDER; HUMAN; MORBIDITY; NEUROCHEMISTRY; OBSESSION; PSYCHOMETRY; REVIEW; SEROTONINERGIC SYSTEM;

ANOREXIA NERVOSA; BULIMIA; CLOMIPRAMINE; COMORBIDITY; FEMALE; FLUOXETINE; HUMANS; MALE; OBSESSIVE-COMPULSIVE DISORDER; PSYCHOMETRICS; SEROTONIN; SEROTONIN UPTAKE INHIBITORS;

EID: 0030043417     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Altamura AC, Montgomery SA, Wernicke JF. 1988. The evidence for 20 mg a day of fluoxetine as the optimal dose for the treatment of depression. Br J Psychiatry 153:109-112.
2. Altemus M, Swedo SE, Leonard HL, Richter D, Rubinow DR, Potter WZ, Rapoport JL. 1994. Changes in cerebrospinal fluid neurochemistry during treatment of obsessive-compulsive disorder with clomipramine. Arch Gen Psychiatry 51:794-803.
3. American Psychiatric Association. 1987. DSM-III-R: Diagnostic and Statistical Manual of Mental Disorders. 3rd ed, rev. Washington DC: American Psychiatric Association.
4. American Psychiatric Association. 1994. DSM-IV: Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington DC: American Psychiatric Association.
5. Ananth J, Pecknold JC, Van Den Steen N, Engelsmann F. 1981. Double-blind comparative study of clomipramine and amitriptyline in obsessive neurosis. Prog Neurol Psychopharmacol 5:25-262.
6. Anderson GH, Kennedy SH, editors. 1992. The biology of feast and famine: relevance to eating disorders. San Diego CA: Academic Press Inc.
7. Baer L, Jenike MA. 1992. Personality disorders in obsessive compulsive disorder. Psychiatri Clin North Am 15:803-812.
8. Baer L, Jenike MA, Ricciardi JN, Holland AD, Seymour RJ, Minichiello WE, Buttolph L. 1990. Standardized assessment of personality disorders in obsessive-compulsive disorder. Arch Gen Psychiatry 47:826-830.
9. Barr LC, Goodman WK, Price LH, McDougle CJ, Charney DS. 1992. The serotonin hypothesis of obsessive compulsive disorder: implications of pharmacologic challenge studies. J Clin Psychiatry 53:(4 Suppl):17S-28S.
10. Bastani B, Arora RC, Meltzer HY. 1991. Serotonin uptake and imipramine binding in the blood platelets of obsessive-compulsive disorder patients. Biol Psychiatry 30:131-139.
11. Benkelfat C, Murphy DL, Zohar J, Hill JL, Grover G, Insel TR. 1989. Clomipramine in obsessive-compulsive disorder. Arch Gen Psychiatry 46:23-28.
12. Beumont PJV, George GCW, Smart DS. 1976. Dieters and vomiters and purgers in anorexia nervosa. Psychol Med 6:617-622.
13. Brewerton TD, Murphy DL, Jimerson DC. 1994. Testmeal responses following m-chlorophenylpiperazine and 1-tryptophan in patients with bulimia and controls. Neuropsychopharmacology 11:63-71.
14. Bulik CM, Beidel DC, Duchmann E, Weltzin TE, Kaye WH. 1992. Comparative psychopathology of women with bulimia nervosa and obsessive-compulsive disorder. Compr Psychiatry 33:262-268.
15. Chaput Y, de Montigny C, Blier P. 1986. Effects of a selective 5-HT blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain. Naunyn-Schmiedeberg's Arch Pharmacol 333:342-348.
16. Charney DS, Goodman WK, Price LH, Woods SW, Rasmussen SA, Heninger GR. 1988. Serotonin function in obsessive-compulsive disorder: a comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects. Arch Gen Psychiatry 45:177-185.
17. Charney DS, Woods SW, Krystal JH, Heninger GR. 1990. Serotonin function and human anxiety disorders. Ann NY Acad Sci 600:558-572.